{
    "2019-01-28": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Thermo Fisher to sell pathology unit for $1.14 billion",
                "features": {
                    "keywords": [
                        "Thermo Fisher",
                        "sell",
                        "pathology unit",
                        "$1.14 billion"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Thermo Fisher Scientific Signs Agreement to Sell its Anatomical Pathology Business",
                "features": {
                    "keywords": [
                        "Thermo Fisher Scientific",
                        "Anatomical Pathology",
                        "Sell",
                        "PHC",
                        "$1.14 Bln"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Does Thermo Fisher Scientific Inc.â€™s (NYSE:TMO) P/E Ratio Signal A Buying Opportunity?",
                "features": {
                    "keywords": [
                        "Thermo Fisher Scientific",
                        "P/E Ratio",
                        "Buying Opportunity",
                        "NYSE:TMO"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}